Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats

Deman Najar1, Börje Haraldsson2, Annika Thorsell3

  • 1Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden. deman.najar@neuro.gu.se.

Toxins
|August 22, 2018
PubMed

Insights

Orellanine, a mushroom toxin, concentrates in kidneys. Its elimination primarily occurs through glomerular filtration and peritoneal dialysis, suggesting potential therapeutic applications.

Area of Science:

  • Toxicology
  • Pharmacokinetics
  • Nephrology

Background:

  • Orellanine, a nephrotoxin from Cortinarius mushrooms, targets proximal tubular cells.
  • Potential therapeutic use in metastatic renal cancer due to cell specificity.
  • Limited understanding of orellanine's distribution and elimination hinders therapeutic development.

Purpose of the Study:

  • To investigate the distribution and pharmacokinetic properties of orellanine in rats.
  • To determine orellanine elimination pathways, including glomerular filtration and peritoneal dialysis.

Main Methods:

  • Intravenous injection of unlabeled and ³H-labeled orellanine (5 mg/kg) in Wistar and Sprague Dawley rats.
  • Distribution analysis using radioluminography.
  • Pharmacokinetic analysis via LC-MS/MS and β-scintillation in control and renal artery-ligated rats, with and without peritoneal dialysis.

Main Results:

  • Highest orellanine concentrations detected in kidney cortex and bladder.
  • Orellanine half-life: 109 ± 6 min in controls.
  • Half-life significantly increased in renal artery-ligated rats (756 ± 98 min without dialysis, 238 ± 28 min with dialysis).

Conclusions:

  • Orellanine is primarily eliminated via glomerular filtration.
  • Peritoneal dialysis effectively enhances orellanine elimination.
  • Findings support further research into orellanine's therapeutic potential for renal cell carcinoma.

Related Concept Videos

Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.6K
Physical and Chemical Properties of Matter02:57

Physical and Chemical Properties of Matter

The characteristics that enable us to distinguish one substance from another are called properties.
166.6K
Properties of Transition Metals02:58

Properties of Transition Metals

Transition metals are defined as those elements that have partially filled d orbitals. As shown in Figure 1, the d-block elements in groups 3–12 are transition elements. The f-block elements, also called inner transition metals (the lanthanides and actinides), also meet this criterion because the d orbital is partially occupied before the f orbitals.
29.9K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.2K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
740